Significats de dysmenorrhoea en anglès

Secondary outcomes included other dysmenorrhoea-related pain outcomes, bleeding profile, satisfaction and safety.

Conclusion: This study establishes the efficacy of aceclofenac-drotaverine combination in patients with primary dysmenorrhoea.

Objective: To evaluate the efficacy and safety of aceclofenac-drotaverine combination against aceclofenac alone in patients with primary dysmenorrhoea.

The descriptions of severe pelvic pain and dysmenorrhoea and dyspareunia by the clinicians were incomplete compared with those of the patients.

The fixed-dose combination of aceclofenac and drotaverine should therefore be considered as a suitable, effective and well tolerated treatment option for primary dysmenorrhoea.